Biolex
From Wikipedia, the free encyclopedia
Biolex Therapeutics is a biotechnology firm in the Research Triangle of North Carolina. The company focuses on formation of difficult to synthesize proteins. Biolex acquired Epicyte Pharmaceutical Inc. on May 6, 2004. The term "plantibody" is trademarked by Biolex.
Biolex is a privately held company backed by Quaker BioVentures, The Trelys Funds, and Polaris Venture Partners.